Table 2 Main reported dimensions of improvements and concerns related to therapy
Users with good access to therapy (G1) (N = 52) | Users with limited access to therapy (G2) (N = 29) | |
|---|---|---|
Reported improvements | n (%) | n (%) |
Physical health | 37 (71.2%) | 8 (27.6%) |
Mental health | 39 (75.0%) | 11 (37.9%) |
Reducing drug cravings | 41 (78.9%) | 4 (13.8%) |
Abstinence from other drugs | 33 (63.5%) | 2 (6.9%) |
Social functioning | 42 (80.8%) | 12 (41.4%) |
Family relations | 34 (65.4%) | 14 (48.3%) |
Self-image and confidence | 44 (84.6%) | 11 (37.9%) |
Avoiding arrest | 47 (90.4%) | 26 (89.7%) |
Reducing financial burden | 50 (96.2%) | 20 (69.0%) |
Reported concerns | n (%) | n (%) |
Dependence to buprenorphine | 29 (55.8%) | 21 (72.4%) |
Treatment side-effects | 9 (17.3%) | 19 (65.5%) |
Geographical access | 7 (13.5%) | 4 (13.8%) |
Time and other logistic constraints | 11 (21.2%) | 8 (27.6%) |
Treatment cost | 6 (11.5%) | 27 (93.1%) |
Difficulty to adhere to treatment protocol | 13 (25.0%) | 19 (65.5%) |